National Health Investors (NHI) FY2024 results: revenue $335 million, up 4.8% on the year
National Health Investors Inc. (NHI) reported revenue of $335 million for fiscal 2024, the year ended 31 December 2024, up 4.8% on the year before. Net income was $138 million, up 1.7%, and diluted earnings per share $3.13. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2025.
Revenue
$335 million
+4.8% on the year
FY2017FY2024
Operating margin
n/a
FY2017FY2024
Net income
$138 million
+1.7% on the year
FY2017FY2024
Diluted EPS
$3.13
0.0% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
208
184
185
+12.6%
Capital expenditure
158
49.6
11.0
+218.7%
Free cash flow
49.8
135
174
-63.1%
Free cash flow margin
14.9%
42.2%
62.7%
Cash from investing
-192
-11.6
198
Cash from financing
-13.6
-170
-401
Depreciation and amortisation
71.4
70.0
n/a
+2.1%
Share-based compensation
4.2
4.6
8.6
-9.2%
Buybacks
0.0
0.0
152
Dividends paid
157
156
162
+0.2%
Dividend per share
$3.60
$3.60
$3.60
0.0%
Diluted shares, weighted
44m
43m
45m
+1.6%
Shares outstanding at period end
46m
43m
43m
+5.2%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
1,366
1,254
1,270
+9.0%
Non-controlling interest
8.9
10.4
9.9
-14.6%
Redeemable equity
9.8
9.7
9.8
+1.4%
Debt
1,146
1,135
1,148
+1.0%
Other liabilities
83.2
79.4
70.0
+4.8%
Total liabilities and equity
2,614
2,488
2,507
+5.1%
Fixed assets
2,211
2,107
2,118
+4.9%
Loans
269
245
233
+9.6%
Cash and equivalents
24.3
22.3
19.3
+8.7%
Receivables
n/a
n/a
3.6
Other assets
110
114
133
-3.4%
Total assets
2,614
2,488
2,507
+5.1%
10-K for the year ended 31 December 2024, filed 25 February 2025: the filing.